Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

3 Dec 2018 15:01

RNS Number : 2748J
Imaginatik PLC
03 December 2018
 

3 December 2018

Imaginatik plc

("Imaginatik" or "the Company")

Issue of Equity

 

Imaginatik plc (AIM: IMTK.L), is pleased to announce that it has conditionally raised gross proceeds of £250,000 via the placing of 20,833,333 new ordinary shares (the "Placing Shares") with new and existing investors (the "Placing") at a price of 1.2p per share.

The net proceeds of the Placing will be used to enable the Company to implement its planned cost reduction programme (delivering £400,000 of savings pa), to provide additional working capital in relation to increasing new business activity and to strengthen the Company's balance sheet.

Application for Admission

Application will be made for the Placing Shares, which will rank pari passu with the Company's existing Ordinary Shares, to be admitted to trading on AIM ("Admission"). It is anticipated that Admission will become effective at 8.00 a.m. on 7 December 2018.

Total voting rights

Following Admission, the Company's enlarged issued share capital will comprise 92,783,006 Ordinary Shares. The Company does not hold any shares in treasury. Therefore, the total number of Ordinary Shares with voting rights will be 92,783,006. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Market soundings, as defined in the Market Abuse Regulation ("MAR"), were taken in respect of the Placing with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement and has been disclosed as soon as possible in accordance with paragraph 7 of article 17 of MAR. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.

 

For further information please contact:

Imaginatik plc

Angus Forrest CEO

 

Via Alma

WH Ireland - Nominated Adviser and Joint Broker

Mike Coe / Chris Savidge

 

Tel: +44 (0)117 945 3470

Peterhouse Capital Limited - Broker

Duncan Vasey / Lucy Williams

 

Tel: +44 (0)20 7220 9797

Alma PR

Caroline Forde / Robyn Fisher

 

Tel: +44 (0)20 8004 4218

About Imaginatik

 

Imaginatik is the leading innovation solution provider, which has combined a proven innovation program with purpose-built idea management software to enable companies to achieve breakthrough and continuous innovation at scale. Imaginatik works with leading global enterprises to build and integrate innovation management skills as a core competency. Customers include ExxonMobil, Altria, TD Bank, Sodexo, Caterpillar and Cargill.

 

For more information visit www.imaginatik.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEEALADESNPFFF
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.